113 related articles for article (PubMed ID: 24399199)
1. Blockade of cannabinoid CB1 and CB2 receptors does not prevent the antipruritic effect of systemic paracetamol.
Saglam G; Gunduz O; Ulugol A
Acta Neurol Belg; 2014 Dec; 114(4):307-9. PubMed ID: 24399199
[TBL] [Abstract][Full Text] [Related]
2. Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist.
Bilir KA; Anli G; Ozkan E; Gunduz O; Ulugol A
Clin Exp Dermatol; 2018 Jul; 43(5):553-558. PubMed ID: 29424035
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of serotonin-induced itch responses by inhibition of endocannabinoid degradative enzymes, fatty acid amide hydrolase and monoacylglycerol lipase.
Tosun NC; Gunduz O; Ulugol A
J Neural Transm (Vienna); 2015 Mar; 122(3):363-7. PubMed ID: 24915981
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats.
Ting CH; Chi CW; Li CP; Chen CY
Nutrition; 2015 Jan; 31(1):230-5. PubMed ID: 25466669
[TBL] [Abstract][Full Text] [Related]
5. The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors.
Dani M; Guindon J; Lambert C; Beaulieu P
Eur J Pharmacol; 2007 Nov; 573(1-3):214-5. PubMed ID: 17651722
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid system involves in the analgesic effect of protocatechuic acid.
Dikmen DY; Okcay Y; Arslan R; Bektas N
Daru; 2019 Dec; 27(2):605-612. PubMed ID: 31325037
[TBL] [Abstract][Full Text] [Related]
7. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
Haller VL; Cichewicz DL; Welch SP
Eur J Pharmacol; 2006 Sep; 546(1-3):60-8. PubMed ID: 16919265
[TBL] [Abstract][Full Text] [Related]
8. The false-positive responses of analgesic drugs to the intradermal serotonin- and compound 48/80-induced scratches as an animal model of itch.
Ilkaya F; Yesilyurt O; Seyrek M; Gunduz O; Ide T; Akar A; Ulugol A; Guzel H; Dogrul A; Ucar D; Gunaydin C
Acta Neurobiol Exp (Wars); 2016; 76(3):234-43. PubMed ID: 27685776
[TBL] [Abstract][Full Text] [Related]
9. Acetaminophen Relieves Inflammatory Pain through CB
Klinger-Gratz PP; Ralvenius WT; Neumann E; Kato A; Nyilas R; Lele Z; Katona I; Zeilhofer HU
J Neurosci; 2018 Jan; 38(2):322-334. PubMed ID: 29167401
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists.
Altun A; Yildirim K; Ozdemir E; Bagcivan I; Gursoy S; Durmus N
J Physiol Sci; 2015 Sep; 65(5):407-15. PubMed ID: 25894754
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
Sain NM; Liang A; Kane SA; Urban MO
Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption.
Onaivi ES; Carpio O; Ishiguro H; Schanz N; Uhl GR; Benno R
Ann N Y Acad Sci; 2008 Oct; 1139():426-33. PubMed ID: 18991890
[TBL] [Abstract][Full Text] [Related]
13. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
[TBL] [Abstract][Full Text] [Related]
14. CB2 cannabinoid receptors promote mouse neural stem cell proliferation.
Molina-Holgado F; Rubio-Araiz A; García-Ovejero D; Williams RJ; Moore JD; Arévalo-Martín A; Gómez-Torres O; Molina-Holgado E
Eur J Neurosci; 2007 Feb; 25(3):629-34. PubMed ID: 17328768
[TBL] [Abstract][Full Text] [Related]
15. CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain.
Deng L; Cornett BL; Mackie K; Hohmann AG
Mol Pharmacol; 2015 Jul; 88(1):64-74. PubMed ID: 25904556
[TBL] [Abstract][Full Text] [Related]
16. The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors.
Ottani A; Leone S; Sandrini M; Ferrari A; Bertolini A
Eur J Pharmacol; 2006 Feb; 531(1-3):280-1. PubMed ID: 16438952
[TBL] [Abstract][Full Text] [Related]
17. 5-HT3 receptors antagonists reduce serotonin-induced scratching in mice.
Ostadhadi S; Kordjazy N; Haj-Mirzaian A; Mansouri P; Dehpour AR
Fundam Clin Pharmacol; 2015 Jun; 29(3):310-5. PubMed ID: 25711853
[TBL] [Abstract][Full Text] [Related]
18. Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats.
Chen L; Zhang J; Li F; Qiu Y; Wang L; Li YH; Shi J; Pan HL; Li M
J Pain; 2009 Jul; 10(7):732-9. PubMed ID: 19409856
[TBL] [Abstract][Full Text] [Related]
19. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.
Teixeira-Clerc F; Julien B; Grenard P; Tran Van Nhieu J; Deveaux V; Li L; Serriere-Lanneau V; Ledent C; Mallat A; Lotersztajn S
Nat Med; 2006 Jun; 12(6):671-6. PubMed ID: 16715087
[TBL] [Abstract][Full Text] [Related]
20. Selective CB2 agonists with anti-pruritic activity: discovery of potent and orally available bicyclic 2-pyridones.
Kusakabe K; Iso Y; Tada Y; Sakagami M; Morioka Y; Chomei N; Shinonome S; Kawamoto K; Takenaka H; Yasui K; Hamana H; Hanasaki K
Bioorg Med Chem; 2013 Jun; 21(11):3154-63. PubMed ID: 23623258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]